| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
RAPT Therapeutics, Inc.
13G
RAPT · 75382E109
|
16.9% |
1/6/2025
Event 12/27/2024
|
||||
| Medicxi IV LP | 16.6% | |||||
| Medicxi Co-Invest IV LP | 0.3% | |||||
| Medicxi IV GP Limited | 16.9% | |||||
| Medicxi Ventures Management (Jersey) Limited | 16.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.